Search

Issue
Title
Authors
Vol 30, No 11 (2023)
Possibilities of overcoming hormone resistance in patients with metastatic HR+ HER2- breast cancer using the drug alpelisib in various subgroups in real clinical practice
Orlova R.V., Gluzman M.I., Vakhitova A.A.
PDF
(Rus)
No 12 (2018)
Ways to improve efficiency of endocrino-therapy of breast cancer: new targeted cells, new therapeutic opportunities
Semiglazov V.F., Semiglazov V.V., Nikolaev K.S., Dashyan G.A., Komyakhov A.V., Paltuev R.M., Appolonova V.S., Donskikh R.V., Tseluyko A.I., Semiglazova T.Y., Zhiltsova E.K., Krivorotko P.V.
PDF
(Rus)
Vol 29, No 9 (2022)
Congenital nephrotic syndrome of the finnish type: a clinical case
Makarova T.P., Samoilova N.V., Melnikova Y.S., Galiullina G.F., Iksanova E.A.
PDF
(Rus)
No 3 (2018)
FEATURES OF ASSOCIATED TRAITS OF 3272-16T>A MUTATION IN CYSTIC FIBROSIS IN CHILDREN: DESCRIPTION OF THREE CASES
Shadrina V.V., Krasovsky S.A., Furman E.G.
PDF
(Rus)
Vol 29, No 1 (2022)
Idiopathic infantile hypercalcemia: a family case
Sadykova D.I., Makarova T.P., Shakirova A.R., Melnikova Y.S., Sergina P.V., Sergina A.V.
PDF
(Rus)
No 9 (2017)
AMIOTROPHIC LATERAL SCLEROSIS IN PATIENTS WITH EXPANSION IN THE C9ORF72 GENE: DESCRIPTION OF CLINICAL CASES
Razinskaya O.D.
PDF
(Rus)
Vol 28, No 7 (2021)
Dermatological toxity of alpelisib: clinical experience and review of current guidelines
Gordeeva O.O., Ganshina I.P., Garifullina V.I.
PDF
(Rus)
No 17 (2016)
CLINICAL CASE O THE EFFECTIVE TREATMENT OF RELAPSE OF ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA WITH BRAF V600E MUTATION USING TARGET DRUG VEMURAFENIB
Naskhletashvili D.R.
PDF
(Rus)
Vol 27, No 7 (2020)
The experience of using the combined targeted regimen vemurafenib+cobimetinib in the treatment of metastatic skin melanoma with a BRAF V600E mutation in a patient with HIV infection receiving antiretroviral therapy
Protsenko S.A., Anokhina E.M., Orlova R.V.
PDF
(Rus)
No 16 (2012)
Monogennye formy sakharnogo diabeta
Zubkova N.A., Tikhonovich Y.V., Tyul'pakov A.N.
PDF
(Rus)
Vol 27, No 7 (2020)
Alpelisib for the treatment of HR+HER2-metastatic breast cancer in patients with the PIK3CA mutation: results of the SOLAR-1 study
Semiglazova T.Y., Semiglazov V.V., Klimenko V.V., Brish N.A., Alekseeva Y.V., Klyuge V.A., Krutov A.A., Paltuev R.M., Kasparov B.S., Krivorotko P.V., Semiglazov V.F.
PDF
(Rus)
No 4 (2012)
[6S]-5-METHYLTETRAHYDROFOLATE INCREASES PLASMA FOLATE MORE EFFECTIVELY THAN FOLIC ACID IN WOMEN WITH THE HOMOZYGOUS OR WILD-TYPE 677C,T POLYMORPHISM OF METHYLENETETRAHYDROFOLATE REDUCTASE *
Prints-Langekhol' R., Bremsvig S., Tobol'ski O., Smul'ders U.M., Smit D.E., Finglas P.M., P'etrtsik L., Prinz-Langenohl R., Brämswig S., Tobolski O., Smulders Y., Smith D., Finglas P., Pietrzik L.
Vol 26, No 7 (2019)
The effectiveness of an integrated approach to the treatment of patients with melanoma with metastatic brain lessions (clinical observation)
Zhukov N.V., Orlova R.V., Antimonik N.Y., Kutukova S.I., Belyak N.P., Vasyusina O.V., Popova N.V.
PDF
(Rus)
No 1 (2009)
Epidemiology and genetics of cystic fibrosis in Udmurt Republic
Simanova T.V., Ozhegov A.M., Simanova T.V., Ozhegov A.M.
Vol 26, No 7 (2019)
Prognostic and predictive values of the PIK3CA gene mutation in patients with breast cancer
Semiglazova T.Y., Sorokina I.V.
PDF
(Rus)
1 - 15 of 15 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies